Daiichi Sankyo Co Ltd
TSE:4568

Watchlist Manager
Daiichi Sankyo Co Ltd Logo
Daiichi Sankyo Co Ltd
TSE:4568
Watchlist
Price: 4 435 JPY -1.49% Market Closed
Market Cap: 8.4T JPY
Have any thoughts about
Daiichi Sankyo Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Daiichi Sankyo Co Ltd stock under the Base Case scenario is 5 494.59 JPY. Compared to the current market price of 4 435 JPY, Daiichi Sankyo Co Ltd is Undervalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
5 494.59 JPY
Undervaluation 19%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Daiichi Sankyo Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Daiichi Sankyo Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Daiichi Sankyo Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Daiichi Sankyo Co Ltd

Provide an overview of the primary business activities
of Daiichi Sankyo Co Ltd.

What unique competitive advantages
does Daiichi Sankyo Co Ltd hold over its rivals?

What risks and challenges
does Daiichi Sankyo Co Ltd face in the near future?

Summarize the latest earnings call
of Daiichi Sankyo Co Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Daiichi Sankyo Co Ltd.

Provide P/S
for Daiichi Sankyo Co Ltd.

Provide P/E
for Daiichi Sankyo Co Ltd.

Provide P/OCF
for Daiichi Sankyo Co Ltd.

Provide P/FCFE
for Daiichi Sankyo Co Ltd.

Provide P/B
for Daiichi Sankyo Co Ltd.

Provide EV/S
for Daiichi Sankyo Co Ltd.

Provide EV/GP
for Daiichi Sankyo Co Ltd.

Provide EV/EBITDA
for Daiichi Sankyo Co Ltd.

Provide EV/EBIT
for Daiichi Sankyo Co Ltd.

Provide EV/OCF
for Daiichi Sankyo Co Ltd.

Provide EV/FCFF
for Daiichi Sankyo Co Ltd.

Provide EV/IC
for Daiichi Sankyo Co Ltd.

Show me price targets
for Daiichi Sankyo Co Ltd made by professional analysts.

What are the Revenue projections
for Daiichi Sankyo Co Ltd?

How accurate were the past Revenue estimates
for Daiichi Sankyo Co Ltd?

What are the Net Income projections
for Daiichi Sankyo Co Ltd?

How accurate were the past Net Income estimates
for Daiichi Sankyo Co Ltd?

What are the EPS projections
for Daiichi Sankyo Co Ltd?

How accurate were the past EPS estimates
for Daiichi Sankyo Co Ltd?

What are the EBIT projections
for Daiichi Sankyo Co Ltd?

How accurate were the past EBIT estimates
for Daiichi Sankyo Co Ltd?

Compare the revenue forecasts
for Daiichi Sankyo Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Daiichi Sankyo Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Daiichi Sankyo Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Daiichi Sankyo Co Ltd compared to its peers.

Compare the P/E ratios
of Daiichi Sankyo Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Daiichi Sankyo Co Ltd with its peers.

Analyze the financial leverage
of Daiichi Sankyo Co Ltd compared to its main competitors.

Show all profitability ratios
for Daiichi Sankyo Co Ltd.

Provide ROE
for Daiichi Sankyo Co Ltd.

Provide ROA
for Daiichi Sankyo Co Ltd.

Provide ROIC
for Daiichi Sankyo Co Ltd.

Provide ROCE
for Daiichi Sankyo Co Ltd.

Provide Gross Margin
for Daiichi Sankyo Co Ltd.

Provide Operating Margin
for Daiichi Sankyo Co Ltd.

Provide Net Margin
for Daiichi Sankyo Co Ltd.

Provide FCF Margin
for Daiichi Sankyo Co Ltd.

Show all solvency ratios
for Daiichi Sankyo Co Ltd.

Provide D/E Ratio
for Daiichi Sankyo Co Ltd.

Provide D/A Ratio
for Daiichi Sankyo Co Ltd.

Provide Interest Coverage Ratio
for Daiichi Sankyo Co Ltd.

Provide Altman Z-Score Ratio
for Daiichi Sankyo Co Ltd.

Provide Quick Ratio
for Daiichi Sankyo Co Ltd.

Provide Current Ratio
for Daiichi Sankyo Co Ltd.

Provide Cash Ratio
for Daiichi Sankyo Co Ltd.

What is the historical Revenue growth
over the last 5 years for Daiichi Sankyo Co Ltd?

What is the historical Net Income growth
over the last 5 years for Daiichi Sankyo Co Ltd?

What is the current Free Cash Flow
of Daiichi Sankyo Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Daiichi Sankyo Co Ltd.

Business Breakdown

Daiichi Sankyo Co., Ltd., a prominent player in the global pharmaceuticals sector, has cemented its position as a leader through innovation and strategic expansion. Founded in 2005 from the merger of Daiichi Pharmaceutical and Sankyo Company, the company has continually focused on research and development, particularly in the fields of oncology, cardiovascular medicine, and vaccines. This dedication has resulted in a robust pipeline of transformative therapies, including the highly anticipated antibody-drug conjugates that address unmet medical needs. Investors are drawn to Daiichi Sankyo not just for its impressive portfolio but also for its commitment to quality and sustainability, underpi...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Daiichi Sankyo Co Ltd

Current Assets 1.9T
Cash & Short-Term Investments 848.5B
Receivables 531.8B
Other Current Assets 515.9B
Non-Current Assets 1.4T
Long-Term Investments 154.5B
PP&E 458.4B
Intangibles 311.4B
Other Non-Current Assets 476.6B
Current Liabilities 643.9B
Accounts Payable 502.8B
Other Current Liabilities 141.1B
Non-Current Liabilities 1T
Long-Term Debt 101.1B
Other Non-Current Liabilities 929.3B
Efficiency

Earnings Waterfall
Daiichi Sankyo Co Ltd

Revenue
1.8T JPY
Cost of Revenue
-420B JPY
Gross Profit
1.3T JPY
Operating Expenses
-1T JPY
Operating Income
303.4B JPY
Other Expenses
-53B JPY
Net Income
250.4B JPY

Free Cash Flow Analysis
Daiichi Sankyo Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Daiichi Sankyo's fiscal Q2 saw revenue rise by 21.5% year-on-year to JPY 882.7 billion, largely driven by strong performances in oncology, specifically from products like Enhertu. Core operating profit surged by 74.8% to JPY 166.6 billion. Notably, the company raised its full-year revenue guidance by JPY 80 billion to JPY 1.83 trillion. This upward revision is influenced by expected sales increases for Lixiana and Enhertu, alongside favorable foreign exchange impacts. The adjusted core operating income forecast also improved by JPY 50 billion to JPY 260 billion, reflecting solid growth momentum.

What is Earnings Call?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Daiichi Sankyo Co Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Years Revenue Growth
Positive Revenue Growth Forecast
60/100
Profitability
Score

Daiichi Sankyo Co Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Daiichi Sankyo Co Ltd's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

91/100
Solvency
Score

Daiichi Sankyo Co Ltd's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Daiichi Sankyo Co Ltd

Wall Street analysts forecast Daiichi Sankyo Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Daiichi Sankyo Co Ltd is 6 562 JPY with a low forecast of 5 656 JPY and a high forecast of 7 980 JPY.

Lowest
Price Target
5 656 JPY
28% Upside
Average
Price Target
6 562 JPY
48% Upside
Highest
Price Target
7 980 JPY
80% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Daiichi Sankyo Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Daiichi Sankyo Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

News

Other Videos

Profile

Daiichi Sankyo Co Ltd Logo
Daiichi Sankyo Co Ltd

Country

Japan

Industry

Pharmaceuticals

Market Cap

8.4T JPY

Dividend Yield

1.35%

Description

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 16,033 full-time employees. The company went IPO on 2005-09-28. The firm is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The firm is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.

Contact

TOKYO-TO
Chuo-Ku
Daiichi Sankyo Bldg. A/B Kan, 3-5-1, Nihombashi Hon-cho
+81362251111.0
www.daiichisankyo.co.jp

IPO

2005-09-28

Employees

16 033

Officers

Group CEO & Executive Chairperson
Mr. Sunao Manabe D.V.M., Ph.D.
President, COO & Representative Director
Mr. Hiroyuki Okuzawa
Senior Managing Exec. Officer, Global Head of Corporate Strategy, Chief Strategy Officer & Director
Mr. Takashi Fukuoka D.V.M., Ph.D.
Senior Managing Executive Officer, Head of Japan Business Unit & Representative Director
Dr. Shoji Hirashima
Managing Ex. Officer, Head of Corporate Planning & Mgt. and CFO
Mr. Koji Ogawa
General Manager of Finance & Accounting Department
Tomohiro Kodama
Show More
Executive Officer & Head of Technology Division
Hiroto Kashiwase
Gen. Counsel, Corp. Officer, Head of Global Legal & IP and VP of Leg. Aff. Dept.
Naoto Tsukaguchi
Head of Global Compliance & Risk Management and Chief Compliance Officer
Matt Allegrucci
Vice President of Corporate Communications Department
Kentaro Asakura
Show Less

See Also

Discover More
What is the Intrinsic Value of one Daiichi Sankyo Co Ltd stock?

The intrinsic value of one Daiichi Sankyo Co Ltd stock under the Base Case scenario is 5 494.59 JPY.

Is Daiichi Sankyo Co Ltd stock undervalued or overvalued?

Compared to the current market price of 4 435 JPY, Daiichi Sankyo Co Ltd is Undervalued by 19%.

Back to Top